These risk factors include blood pressure, cholesterol, and chronic inflammation [3]
Food and Drug Administration has identified certain bulk drug substances used in compounding as substances that may present significant safety risks, and BPC-157 has been discussed in that regulatory context
Its not
Semaglutide under the brand names Ozempic and Wegovy, tirzepatide under the names Mounjaro and Zepbound, and other medications in this class have demonstrated meaningful results for weight management and blood sugar control that go beyond what most previous treatment options could offer
If the hair loss is shedding, it is usually temporary and improves once the body adjusts, weight stabilizes, and nutrition is optimized, he says
Photograph of DiMarchi, credit: Indiana University